Home Blog Page 9

OPRM1 Genetic Test: Opioid Response, Pain Treatment, and Results

Understand what an OPRM1 genetic test shows, how AA, AG, and GG results relate to opioid response, why dosing guidance is limited, and how to use results safely.

An OPRM1 genetic test looks for inherited variation in the gene that makes the mu-opioid receptor, a major target of medicines such as morphine,...

Pain Medication Pharmacogenetic Test: Opioids, CYP2D6, OPRM1, and Results

Learn how pain medication pharmacogenetic testing uses CYP2D6, OPRM1, and related genes to clarify opioid response, codeine and tramadol risks, test results, and treatment choices.

A pain medication pharmacogenetic test looks for inherited gene variants that may change how a person processes or responds to certain analgesics. The clearest...

Pharmacogenetic Panel Test: Medication Response, Gene Variants, and Results

Understand what a pharmacogenetic panel test measures, which medication-response genes may be actionable, how results are interpreted, and how panels can guide safer prescribing.

A pharmacogenetic panel test examines several inherited genes at once to identify medication responses that may differ from the average. It can reveal slower...

Psychiatric Pharmacogenetic Test: Antidepressants, Antipsychotics, Genes, and Results

Learn what psychiatric pharmacogenetic testing can and cannot predict for antidepressants and antipsychotics, including CYP2D6, CYP2C19, SLC6A4, results, limits, and safe treatment use.

A psychiatric pharmacogenetic test analyzes inherited gene variants that may affect the metabolism, exposure, or tolerability of selected antidepressants and antipsychotics. The strongest prescribing...

RYR1 Genetic Test: Malignant Hyperthermia Risk and Anesthesia Results

Learn how RYR1 genetic testing evaluates malignant hyperthermia susceptibility, what positive, negative, and uncertain results mean, and how to plan safe trigger-free anesthesia.

An RYR1 genetic test looks for inherited variants associated with malignant hyperthermia susceptibility, a potentially fatal reaction to certain general anesthetics and the muscle...

SLC6A4 Genetic Test: Antidepressant Response, Serotonin Transporter, and Results

Understand SLC6A4 genetic testing, 5-HTTLPR and rs25531 results, the evidence on SSRI response, why guidelines do not recommend stand-alone prescribing changes, and how to use findings safely.

An SLC6A4 genetic test examines variants in the gene that encodes the serotonin transporter, the protein blocked by selective serotonin reuptake inhibitor antidepressants. The...

SLCO1B1 Genetic Test: Statin Muscle Risk, Simvastatin, and Results

Learn what an SLCO1B1 genetic test reveals about simvastatin exposure and statin muscle-risk, how results are reported, and how clinicians may use them safely.

An SLCO1B1 genetic test looks for inherited variants that can reduce the liver’s uptake of certain statins, especially simvastatin. When that transport is reduced,...

Statin Pharmacogenetic Test: SLCO1B1, Muscle Pain Risk, and Results

Understand how a statin pharmacogenetic test uses SLCO1B1, ABCG2, and CYP2C9 results to assess muscle-risk and guide safer, effective statin choices.

A statin pharmacogenetic test examines inherited variants that can change how the body transports or metabolizes cholesterol-lowering medicines. The most clinically established finding is...

Tacrolimus Pharmacogenetic Test: CYP3A5, Dose, Transplant, and Results

Learn how CYP3A5 pharmacogenetic testing can guide an initial tacrolimus dose after transplant, how results are interpreted, and why trough monitoring remains essential.

A tacrolimus pharmacogenetic test examines CYP3A5, a gene that strongly influences how quickly many transplant recipients clear tacrolimus. People who make functional CYP3A5 enzyme—called...

Thiopurine Pharmacogenetic Test: TPMT, NUDT15, Toxicity Risk, and Results

Learn how TPMT and NUDT15 pharmacogenetic testing predicts thiopurine toxicity risk, guides safer starting doses, and works with ongoing blood-count monitoring.

A thiopurine pharmacogenetic test examines TPMT and NUDT15, two genes that strongly influence tolerance to azathioprine, mercaptopurine, and thioguanine. Reduced function in either pathway...

TPMT Genetic Test: Thiopurine Toxicity, Azathioprine, Mercaptopurine, and Results

Learn how a TPMT genetic test predicts azathioprine and mercaptopurine toxicity risk, how metabolizer results guide starting doses, and why NUDT15 and blood monitoring still matter.

A TPMT genetic test identifies inherited variants that reduce thiopurine S-methyltransferase activity and increase sensitivity to azathioprine, mercaptopurine, and thioguanine. TPMT normally helps divert...

UGT1A1 Genetic Test: Irinotecan Toxicity, Gilbert Syndrome, and Results

Learn how UGT1A1 testing can predict irinotecan toxicity risk, support a Gilbert syndrome diagnosis, and clarify the meaning of *28, *6, and metabolizer results.

A UGT1A1 genetic test has two main clinical uses. In oncology, it can identify patients who clear the active irinotecan metabolite SN-38 more slowly...

VKORC1 Genetic Test: Warfarin Sensitivity, Dose, and Results

Learn how a VKORC1 genetic test predicts warfarin sensitivity, what G/G, G/A, and A/A results mean, and why dosing still requires CYP2C9 data and INR monitoring.

A VKORC1 genetic test examines inherited variation in the gene that makes warfarin’s molecular target. The result most often reported, VKORC1 c.-1639G>A (rs9923231), helps...

Warfarin Pharmacogenetic Test: CYP2C9, VKORC1, CYP4F2, Dose, and Results

Understand how a warfarin pharmacogenetic test uses CYP2C9, VKORC1, CYP4F2, and ancestry-aware results to estimate dose while INR monitoring guides safe treatment.

A warfarin pharmacogenetic test analyzes inherited variants that help explain why one person may need 1 mg of warfarin a day while another needs...

Alzheimer Disease Genetic Test: APOE, APP, PSEN1, PSEN2, and Results

Understand Alzheimer disease genetic testing for APOE, APP, PSEN1, and PSEN2, including who should test, result meanings, family risk, and treatment safety.

Alzheimer disease genetic testing can answer very different questions depending on which genes are examined. Rare pathogenic variants in APP, PSEN1, or PSEN2 can...

Amyotrophic Lateral Sclerosis (ALS) Genetic Test: C9orf72, SOD1, TARDBP, and Results

Learn how ALS genetic testing evaluates C9orf72, SOD1, TARDBP, FUS, and other genes, what results mean, and how findings can affect treatment and family risk.

ALS genetic testing looks for inherited or disease-associated changes that may explain why motor neurons are degenerating. The most important first-line targets include the...

Angelman Syndrome Genetic Test: UBE3A, Methylation, Deletion, and Results

Understand Angelman syndrome genetic testing for UBE3A, methylation, deletions, uniparental disomy, and imprinting defects, including results and recurrence risk.

Angelman syndrome testing does more than look for a change in the UBE3A gene. The condition results from loss of the active maternal UBE3A...

APOE Genotype Test: Alzheimer Disease Risk, Cholesterol, and Results

Learn what an APOE genotype test shows about Alzheimer disease risk, cholesterol disorders, anti-amyloid treatment safety, and ε2, ε3, and ε4 results.

An APOE genotype test identifies which common APOE alleles—ε2, ε3, or ε4—you inherited from each biological parent. The result can inform several separate clinical...

Autism Genetic Testing: Chromosomal Microarray, Exome Sequencing, and Results

Learn how chromosomal microarray, exome sequencing, genome sequencing, and targeted tests are used in autism, what results mean, and how findings may guide care.

Genetic testing does not diagnose autism; autism is diagnosed from development, communication, behavior, and clinical observation. Genetic testing looks for an underlying chromosome or...

Becker Muscular Dystrophy Genetic Test: DMD Gene, Muscle Weakness, and Results

Learn how Becker muscular dystrophy genetic testing detects DMD deletions, duplications, and sequence variants, and what results mean for weakness, heart care, and family risk.

Becker muscular dystrophy testing looks for a pathogenic change in the DMD gene, which provides instructions for making dystrophin. Becker muscular dystrophy usually occurs...